respiratory
COPD

Use of ICS in COPD should be individualised say experts


Inhaled corticosteroids should only be used as an add-on therapy in patients with COPD and their addition to LABA maintenance therapy in these patients must be personalised, agree international respiratory experts. Tackling the much-debated topic of the efficacy, safety and positioning of ICS in the treatment of COPD, the group critically reviewed the evidence for ...

Already a member?

Enter your email to keep reading.


OR